Interdomain binding mediates tumor growth suppression by the NF2 gene product

被引:187
作者
Sherman, L
Xu, HM
Geist, RT
SaporitoIrwin, S
Howells, N
Ponta, H
Herrlich, P
Gutmann, DH
机构
[1] WASHINGTON UNIV,SCH MED,DEPT NEUROL,ST LOUIS,MO 63110
[2] FORSCHUNGSZENTRUM KARLSRUHE,INST GENET,D-76021 KARLSRUHE,GERMANY
基金
美国国家卫生研究院;
关键词
merlin; negative growth regulator; tumor suppressor gene; schwannomin; schwannoma; ERM proteins;
D O I
10.1038/sj.onc.1201418
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The neurofibromatosis 2 (NF2) tumor suppressor gene encodes an intracellular membrane-associated protein, called merlin (or schwannomin), that belongs to the band 4.1 family of cytoskeleton-associated proteins, Inactivating NF2 mutations occur in several sporadic tumor types and have been linked to the NF2 disease, whose hallmark is the development of bilateral Schwann cell tumors (schwannomas) of the eighth cranial nerve, Two major alternatively spliced NI;2 variants are expressed in normal tissues:'NF2-17 lacking exon 16 and 'NF2-16' that contains exon 16 and encodes a merlin protein truncated at the C-terminus, We report that overexpression of NF2-17 in rat schwannoma cells inhibits their growth in vitro and in vivo, while NF2-16 fails to influence schwannoma growth, Tumor growth inhibition by merlin depends on an interdomain association occurring either in cis or in hans between the N- and C-termini, This association does not occur in the truncated NF2-16 protein nor in a mutant NF2-17 protein lacking C-terminal sequences, These data indicate that merlin has a unique mechanism of tumor suppression, inhibiting cell proliferation via self-association.
引用
收藏
页码:2505 / 2509
页数:5
相关论文
共 31 条
  • [1] HIGH-FREQUENCY OF INACTIVATING MUTATIONS IN THE NEUROFIBROMATOSIS TYPE-2 GENE (NF2) IN PRIMARY MALIGNANT MESOTHELIOMAS
    BIANCHI, AB
    MITSUNAGA, SI
    CHENG, JQ
    KLEIN, WM
    JHANWAR, SC
    SEIZINGER, B
    KLEY, N
    KLEINSZANTO, AJP
    TESTA, JR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (24) : 10854 - 10858
  • [2] MUTATIONS IN TRANSCRIPT ISOFORMS OF THE NEUROFIBROMATOSIS-2 GENE IN MULTIPLE HUMAN TUMOR TYPES
    BIANCHI, AB
    HARA, T
    RAMESH, V
    GAO, JZ
    KLEINSZANTO, AJP
    MORIN, F
    MENON, AG
    TROFATTER, JA
    GUSELLA, JF
    SEIZINGER, BR
    KLEY, N
    [J]. NATURE GENETICS, 1994, 6 (02) : 185 - 192
  • [3] BIJISMA E, 1995, HUM GENET, V96, P1
  • [4] DENBAKKER MA, 1995, ONCOGENE, V10, P757
  • [5] DIAGNOSTIC ISSUES IN A FAMILY WITH LATE-ONSET TYPE-2 NEUROFIBROMATOSIS
    EVANS, DGR
    BOURN, D
    WALLACE, A
    RAMSDEN, RT
    MITCHELL, JD
    STRACHAN, T
    [J]. JOURNAL OF MEDICAL GENETICS, 1995, 32 (06) : 470 - 474
  • [6] EZRIN SELF-ASSOCIATION INVOLVES BINDING OF AN N-TERMINAL DOMAIN TO A NORMALLY MASKED C-TERMINAL DOMAIN THAT INCLUDES THE F-ACTIN BINDING-SITE
    GARY, R
    BRETSCHER, A
    [J]. MOLECULAR BIOLOGY OF THE CELL, 1995, 6 (08) : 1061 - 1075
  • [7] GonzalezAgosti C, 1996, ONCOGENE, V13, P1239
  • [8] EXPRESSION OF THE NEUROFIBROMATOSIS-2 (NF2) GENE ISOFORMS DURING RAT EMBRYONIC-DEVELOPMENT
    GUTMANN, DH
    WRIGHT, DE
    GEIST, RT
    SNIDER, WD
    [J]. HUMAN MOLECULAR GENETICS, 1995, 4 (03) : 471 - 478
  • [9] Gutmann DH, 1995, INT J DEV BIOL, V39, P895
  • [10] Loss of merlin expression in sporadic meningiomas, ependymomas and schwannomas
    Gutmann, DH
    Giordano, MJ
    Fishback, AS
    Guha, A
    [J]. NEUROLOGY, 1997, 49 (01) : 267 - 270